Education
About Us
Working with TipRanks
Follow Us
Abivax SA Sponsored ADR (ABVX)
NASDAQ:ABVX
ABVX Stock Chart & Stats
$90.47
-$0.09(-1.29%)
At close: 4:00 PM EST
$90.47
-$0.09(-1.29%)
Day’s Range― - ―
52-Week Range$4.77 - $98.64
Previous CloseN/A
Volume62.24K
Average Volume (3M)999.49K
Market Cap
$7.18B
Enterprise Value$513.05M
Total Cash (Recent Filing)$60.95M
Total Debt (Recent Filing)$98.71M
Price to Earnings (P/E)―
Beta2.31
Next Earnings
Dec 15, 2025EPS Estimate
-0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.38
Shares Outstanding77,828,920
10 Day Avg. Volume1,034,726
30 Day Avg. Volume999,494
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)10.98
Price to Sales (P/S)41.30
P/FCF Ratio-2.88
Enterprise Value/Market Cap0.07
Enterprise Value/Revenue54.49
Enterprise Value/Gross Profit54.49
Enterprise Value/Ebitda-2.27
Forecast
1Y Price Target
$121.25Price Target Upside34.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Company FinancialsAbivax no longer holds any debt with Heights Capital Management.
Drug EfficacyObefazimod shows robust activity in advanced treatment refractory ulcerative colitis, confirming its potential for broad use across the treatment paradigm.
Market PotentialFeedback from 5 KOLs supports strong commercial potential for obefazimod in UC.
Bears Say
Financial SustainabilityAnnualized cash burn is $205.0 million with the company having approximately 2.5 years of cash left.
Abivax SA Sponsored ADR News
ABVX FAQ
What was Abivax SA Sponsored ADR’s price range in the past 12 months?
Abivax SA Sponsored ADR lowest stock price was $4.77 and its highest was $98.64 in the past 12 months.
What is Abivax SA Sponsored ADR’s market cap?
Abivax SA Sponsored ADR’s market cap is $7.18B.
When is Abivax SA Sponsored ADR’s upcoming earnings report date?
Abivax SA Sponsored ADR’s upcoming earnings report date is Dec 15, 2025 which is in 51 days.
How were Abivax SA Sponsored ADR’s earnings last quarter?
Abivax SA Sponsored ADR released its earnings results on Sep 08, 2025. The company reported -$1.376 earnings per share for the quarter, missing the consensus estimate of -$0.929 by -$0.447.
Is Abivax SA Sponsored ADR overvalued?
According to Wall Street analysts Abivax SA Sponsored ADR’s price is currently Undervalued.
Does Abivax SA Sponsored ADR pay dividends?
Abivax SA Sponsored ADR does not currently pay dividends.
What is Abivax SA Sponsored ADR’s EPS estimate?
Abivax SA Sponsored ADR’s EPS estimate is -0.73.
How many shares outstanding does Abivax SA Sponsored ADR have?
Abivax SA Sponsored ADR has 77,828,920 shares outstanding.
What happened to Abivax SA Sponsored ADR’s price movement after its last earnings report?
Abivax SA Sponsored ADR reported an EPS of -$1.376 in its last earnings report, missing expectations of -$0.929. Following the earnings report the stock price went down -0.833%.
Which hedge fund is a major shareholder of Abivax SA Sponsored ADR?
Currently, no hedge funds are holding shares in ABVX
Abivax SA Sponsored ADR Stock Smart Score
Company Description
Abivax SA Sponsored ADR
Abivax SA is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic treatments for inflammatory diseases and viral infections, including its lead product candidate ABX464, which is being investigated for the treatment of ulcerative colitis and other indications. The company operates primarily in the biotechnology sector, leveraging its proprietary technologies to discover and develop innovative therapies that address significant unmet medical needs.
ABVX Stock 12 Month Forecast
Average Price Target
$121.25
▲(34.02% Upside)
Technical Analysis
Cytokinetics
―
Rhythm Pharmaceuticals
―
Legend Biotech
―
Avidity Biosciences
―
Nuvalent
―
Ownership Overview
―
Insiders
1.59% Mutual Funds
<0.01% Other Institutional Investors
98.33% Public Companies and
Individual Investors